237 related articles for article (PubMed ID: 38303712)
1. Profiling of ERBB receptors and downstream pathways reveals selectivity and hidden properties of ERBB4 antagonists.
Popović L; Wintgens JP; Wu Y; Brankatschk B; Menninger S; Degenhart C; Jensen N; Wichert SP; Klebl B; Rossner MJ; Wehr MC
iScience; 2024 Feb; 27(2):108839. PubMed ID: 38303712
[TBL] [Abstract][Full Text] [Related]
2. Protocol for identifying properties of ERBB receptor antagonists using the barcoded ERBBprofiler assay.
Popović L; Rossner MJ; Wehr MC
STAR Protoc; 2024 Apr; 5(2):102987. PubMed ID: 38635397
[TBL] [Abstract][Full Text] [Related]
3. The Q43L mutant of neuregulin 2β is a pan-ErbB receptor antagonist.
Wilson KJ; Mill CP; Gallo RM; Cameron EM; VanBrocklin H; Settleman J; Riese DJ
Biochem J; 2012 Apr; 443(1):133-44. PubMed ID: 22216880
[TBL] [Abstract][Full Text] [Related]
4. System-wide investigation of ErbB4 reveals 19 sites of Tyr phosphorylation that are unusually selective in their recruitment properties.
Kaushansky A; Gordus A; Budnik BA; Lane WS; Rush J; MacBeath G
Chem Biol; 2008 Aug; 15(8):808-17. PubMed ID: 18721752
[TBL] [Abstract][Full Text] [Related]
5. Targeting ErbB receptors in high-grade glioma.
Berezowska S; Schlegel J
Curr Pharm Des; 2011; 17(23):2468-87. PubMed ID: 21827413
[TBL] [Abstract][Full Text] [Related]
6. Cancer regulator EGFR-ErbB4 heterodimer is stabilized through glycans at the dimeric interface.
Motamedi Z; Shahsavari M; Rajabi-Maham H; Azimzadeh Irani M
J Mol Model; 2022 Nov; 28(12):399. PubMed ID: 36427180
[TBL] [Abstract][Full Text] [Related]
7. Small molecule inhibitors targeting the EGFR/ErbB family of protein-tyrosine kinases in human cancers.
Roskoski R
Pharmacol Res; 2019 Jan; 139():395-411. PubMed ID: 30500458
[TBL] [Abstract][Full Text] [Related]
8. Prognostic value of ERBB family mRNA expression in breast carcinomas.
Bièche I; Onody P; Tozlu S; Driouch K; Vidaud M; Lidereau R
Int J Cancer; 2003 Sep; 106(5):758-65. PubMed ID: 12866037
[TBL] [Abstract][Full Text] [Related]
9. ErbB2 and ErbB3 do not quantitatively modulate ligand-induced ErbB4 tyrosine phosphorylation.
Feroz K; Williams E; Riese DJ
Cell Signal; 2002 Sep; 14(9):793-8. PubMed ID: 12034361
[TBL] [Abstract][Full Text] [Related]
10. ErbB receptors mediate both migratory and proliferative activities in human melanocytes and melanoma cells.
Gordon-Thomson C; Jones J; Mason RS; Moore GP
Melanoma Res; 2005 Feb; 15(1):21-8. PubMed ID: 15714117
[TBL] [Abstract][Full Text] [Related]
11. ErbB receptors, their ligands, and the consequences of their activation and inhibition in the myocardium.
Fuller SJ; Sivarajah K; Sugden PH
J Mol Cell Cardiol; 2008 May; 44(5):831-54. PubMed ID: 18430438
[TBL] [Abstract][Full Text] [Related]
12. Co-localization of multiple ErbB receptors in stratified epithelium of oral squamous cell carcinoma.
Bei R; Pompa G; Vitolo D; Moriconi E; Ciocci L; Quaranta M; Frati L; Kraus MH; Muraro R
J Pathol; 2001 Oct; 195(3):343-8. PubMed ID: 11673832
[TBL] [Abstract][Full Text] [Related]
13. secErbB4-26/549 antagonizes ligand-induced ErbB4 tyrosine phosphorylation.
Gilmore JL; Riese DJ
Oncol Res; 2004; 14(11-12):589-602. PubMed ID: 15667000
[TBL] [Abstract][Full Text] [Related]
14. Ligand discrimination in signaling through an ErbB4 receptor homodimer.
Sweeney C; Lai C; Riese DJ; Diamonti AJ; Cantley LC; Carraway KL
J Biol Chem; 2000 Jun; 275(26):19803-7. PubMed ID: 10867024
[TBL] [Abstract][Full Text] [Related]
15. Role of epidermal growth factor receptor signaling in the interaction of Neisseria meningitidis with endothelial cells.
Slanina H; Mündlein S; Hebling S; Schubert-Unkmeir A
Infect Immun; 2014 Mar; 82(3):1243-55. PubMed ID: 24379285
[TBL] [Abstract][Full Text] [Related]
16. ErbB4 promotes malignant peripheral nerve sheath tumor pathogenesis via Ras-independent mechanisms.
Longo JF; Brosius SN; Black L; Worley SH; Wilson RC; Roth KA; Carroll SL
Cell Commun Signal; 2019 Jul; 17(1):74. PubMed ID: 31291965
[TBL] [Abstract][Full Text] [Related]
17. Ligand stimulation of ErbB4 and a constitutively-active ErbB4 mutant result in different biological responses in human pancreatic tumor cell lines.
Mill CP; Gettinger KL; Riese DJ
Exp Cell Res; 2011 Feb; 317(4):392-404. PubMed ID: 21110957
[TBL] [Abstract][Full Text] [Related]
18. Systematic analysis and molecular profiling of EGFR allosteric inhibitor cross-reactivity across the proto-oncogenic ErbB family kinases by integrating dynamics simulation, energetics calculation and biochemical assay.
Ma Y; Qi B; Ning M; Zhang L; An Z; Zhao J
Eur Biophys J; 2022 Apr; 51(3):283-295. PubMed ID: 35307752
[TBL] [Abstract][Full Text] [Related]
19. Stretch-induced fetal type II cell differentiation is mediated via ErbB1-ErbB4 interactions.
Huang Z; Wang Y; Nayak PS; Dammann CE; Sanchez-Esteban J
J Biol Chem; 2012 May; 287(22):18091-102. PubMed ID: 22493501
[TBL] [Abstract][Full Text] [Related]
20. ErbB receptors in fetal endothelium--a potential linkage point for inflammation-associated neonatal disorders.
Bueter W; Dammann O; Zscheppang K; Korenbaum E; Dammann CE
Cytokine; 2006 Dec; 36(5-6):267-75. PubMed ID: 17379533
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
